Co-pay and Advancing Access®

INDICATION

DESCOVY® for HIV-1 pre-exposure prophylaxis (PrEP) is indicated in at-risk adults and adolescents (≥35 kg) to reduce the risk of sexually acquired HIV-1 infection, excluding individuals at risk from receptive vaginal sex. HIV-1–negative status must be confirmed immediately prior to initiation.

Limitation of Use: DESCOVY FOR PrEP is not indicated in individuals at risk of HIV-1 from receptive vaginal sex because effectiveness in this population has not been evaluated.

Immediate coverage across major plans

Eligible patients may pay as little as a $0 co-pay*



Gilead Advancing Access image

Get Patients Started


OR CALL

1-800-226-2056

Monday–Friday
9 AM to 8 PM ET

The co-pay coupon card covers up to $7200 per year for DESCOVY®, with no monthly limit for eligible patients.

The Gilead Advancing Access program can help patients with:
  • Insurance Support: Provides help with coverage and benefits investigations, and information regarding prior authorizations and alternative coverage options
  • Financial Support: Connects patients to appropriate financial assistance, including co‑pay support, alternative funding information, and the Medication Assistance Program

*For eligible, commercially insured patients only. See full terms and conditions at gileadadvancingaccess.com/hcp. This is not health insurance. Only accepted at participating pharmacies.